Safety and efficacy of neublastin in painful lumbosacral radiculopathy: a randomized, double-blinded, placebo-controlled phase 2 trial using Bayesian adaptive design (the SPRINT trial).

Placebo-adjusted differences for reduction in ABPI were also greater at weeks 1 and 3 than at week 5, but the difference vs placebo did not reach statistical significance at any time point (Table 2 ). 3.4.

also in 111,027 other papers